PACS Group (NYSE:PACS) FY Conference Summary Company Overview - **Company**: PACS Group - **Industry**: Healthcare, specifically post-acute care - **Mission**: To revolutionize the delivery, leadership, and quality of post-acute healthcare nationally [2][3] Core Insights and Arguments - **Growth Strategy**: PACS Group has developed a unique operating model that emphasizes locally led, centrally supported management, allowing administrators to act as local CEOs [5]. This model has been effective in improving underperforming facilities and scaling operations [7][10]. - **Market Position**: The company operates 323 facilities, with a focus on high-quality care, achieving an occupancy rate of approximately 95% for mature facilities, which is considered industry-leading [12][14]. - **Financial Performance**: - Total revenue for 2025 was $5.29 billion, reflecting nearly 30% year-over-year growth [14]. - Adjusted EBITDA for 2025 was $505 million, with Q4 revenue reaching $1.36 billion, up 12% year-over-year [14][19]. - The company expects 2026 revenue to be between $5.65 billion and $5.75 billion, indicating an 8% growth from 2025 [19][20]. Operational Highlights - **Occupancy Metrics**: - Mature facilities had an occupancy rate of nearly 95%, while ramping facilities averaged over 86% [15]. - New facilities averaged just over 81% occupancy, reflecting ongoing stabilization efforts [17]. - **Quality Measures**: The company boasts a Quality Measure (QM) rating of 4.4 out of 5.0 across its portfolio, indicating best-in-class performance in the sector [13]. Acquisition Strategy - **M&A Pipeline**: The company has a strong acquisition pipeline, with hundreds of opportunities identified annually. PACS focuses on acquiring underperforming facilities, which typically have occupancy rates of 60%-70% [30][31]. - **Market Share**: PACS currently holds about 3% of the market share, indicating significant growth potential as the demand for transitional care services increases [30][34]. Challenges and Legal Matters - **Ongoing Investigations**: The company is currently under investigation by the DOJ, following a short report published in November 2024. The management has been cooperative and is working towards a resolution [22][23][25]. - **Impact of Investigations**: Despite the challenges posed by the investigations, management asserts that the company is in a strong position, having improved its operational and compliance capabilities during this period [39][40]. Future Outlook - **2026 Guidance**: The company anticipates continued growth and margin expansion, primarily driven by organic growth and improved occupancy rates [20][41]. - **Optimism for Growth**: Management expresses confidence in the company's ability to execute its business plans and deliver value to patients and shareholders, emphasizing that the organization is better positioned now than ever before [39][41]. Additional Important Points - **Demographic Trends**: The aging baby boomer population is driving demand for PACS's services, which positions the company well for future growth [33]. - **Operational Excellence**: The company emphasizes the importance of high-quality care as a key driver of demand and occupancy, reinforcing its commitment to improving patient outcomes [36].

Core Insights - BrightSpring Health Services, Inc. (NASDAQ:BTSG) is highlighted as a top digital health stock following a strong Q3 performance, with UBS analyst A.J. Rice reiterating a Buy rating and raising the 12-month price target to $42 from $35, driven by management's confidence and growth momentum in specialty and infusion services [1][3]. Financial Performance - For Q3, BrightSpring reported revenue of $3.334 billion, reflecting a year-over-year increase of 28.2%, adjusted EBITDA of $160 million, up 37.2% YoY, and a net income of $37.5 million compared to a loss in the previous year [2][3]. - The Pharmacy Solutions segment experienced significant growth, increasing approximately 31% to $2.97 billion, while Provider Services rose about 9% to $367 million [3]. Future Guidance - Management has raised the full-year 2025 revenue guidance to a range of $12.4 billion to $12.7 billion, while maintaining adjusted EBITDA guidance at $605 million to $615 million, indicating continued strength in specialty volume and execution on the pharmacy platform [3]. Company Overview - BrightSpring Health Services operates in the post-acute care sector, providing home and community-based clinical services and pharmacy solutions across the United States, catering to medically complex and aging populations through in-home care, behavioral health support, and medication management [4].

E N S I G N G R O U P INVESTOR PRESENTATION N o v e m b e r 2 0 2 5 w w w . e n s i g n g r o u p . n e t R: 105 G: 127 B: 87 #697F57 R: 172 G:200 B: 182 #ACC8B6 R: 0 G: 79 B: 103 #004F67 R: 153 G: 153 B: 204 #9999CC R: 252 G: 97 B: 92 #FC615C Primary Colors R: 0 G: 195 B: 255 #00C3FF R: 49 G: 131 B: 146 #008598 R: 68 G: 108 B: 120 # 446c78 R: 173 G: 106 B: 156 # b06a9b R: 148 G: 145 B: 147 #949193 R: 69 G: 110 B: 83 # 456E53 R: 41 G: 97 B: 99 # 296163 R: 47 G: 94 B: 84 # 2F5E54 Prevent Page Cut-off: File > ...

Company Overview - PACS Group, Inc. is a leading post-acute care provider operating 316 facilities across 17 states, with over 32,000 skilled nursing beds and 2,400 assisted living beds, focusing on quality care [2] - The company has expanded rapidly since Q2 2024, adding 96 facilities to its portfolio [2] Financial Performance - As of June 30, PACS reported an occupancy rate of 88.9%, significantly higher than the industry average of 78% [3] - The company has cash reserves of $294.2 million, nearly double the levels at the end of 2024 [3] - Management projects record revenue and adjusted EBITDA for the first half of 2025 once financial filings are complete [3] Regulatory and Governance Issues - The New York Stock Exchange extended PACS's trading period to November 19, 2025, allowing more time for the company to complete financial restatements and SEC filings [3] - PACS is cooperating with an independent Audit Committee investigation into past financial matters [3] - Leadership changes occurred with the resignation of CFO Derick Apt after an internal policy investigation, and a former CFO has been appointed as interim [4]

Company Overview - The Ensign Group, Inc. (ENSG) has been providing post-acute care since 1999 through its independent subsidiaries [6] - The company operates 343 facilities with over 38,000 beds/units across the care continuum and employs more than 50,500 individuals [18] - The company has experienced a 15% annual revenue growth rate and a 16% annual EBITDAR growth rate since 2014 [18] Financial Performance and Guidance - The company's 2025 revenue guidance is $4.91 billion [18] - The company's 2025 EPS guidance is $6.30 [18] - Q1 2025 revenue reached $1.173 billion, a 16.1% increase compared to Q1 2024 [113] - Same facility skilled nursing facility revenue increased by 5.6% in Q1 2025 compared to Q1 2024 [113] - Consolidated adjusted net income increased by 18.0% in Q1 2025 compared to Q1 2024, reaching $89 million [113] Portfolio and Acquisitions - The company operates in 17 states [19, 35] - The company has 143 owned properties [19] - The company's occupancy rate is 82.6% [19] - The company's skilled mix days is 33.1% [19] - The company completed 73 acquisitions since 2023 [22] - The company completed 16 acquisitions from January 1, 2025, to April 1, 2025 [21] Standard Bearer REIT - Standard Bearer REIT has 137 properties with a real estate fair value of $1.5 billion [85] - Standard Bearer REIT operates in 16 states with 13,920 operating beds/units [85] - Standard Bearer REIT has a weighted average lease tenor of 14.3 years [85, 91] - 98% of Standard Bearer REIT's leases expire after 2031 [92] - Standard Bearer REIT's total rental revenue for Q1 2025 was $28.401 million, including $4.497 million from third-party tenants and $23.904 million from Ensign's independent subsidiaries [146]

As filed with the Securities and Exchange Commission on April 1, 2024. Registration No. 333-277893 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 PACS Group, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) 262 N. University Ave. Farmington, Utah 84025 (801) 447-9829 (Add ...